Greenwood Capital Associates’s JPMorgan International Research Enhanced Equity ETF JIRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.5M Buy
139,052
+8,635
+7% +$693K 1.13% 19
2026
Q1
$9.88M Buy
130,417
+2,254
+2% +$176K 1.09% 18
2025
Q4
$9.6M Buy
128,163
+28,404
+28% +$2.12M 1.04% 23
2025
Q3
$7.34M Buy
99,759
+17,188
+21% +$1.23M 0.85% 37
2025
Q2
$5.84M Buy
82,571
+22,437
+37% +$1.5M 0.73% 43
2025
Q1
$3.83M Buy
60,134
+16,228
+37% +$1.02M 0.52% 71
2024
Q4
$2.57M Buy
+43,906
New +$2.74M 0.34% 80

Other funds holding JIRE

Greenwood Capital Associates's JIRE Position: Q2 2026 in Review

Greenwood Capital Associates increased its JPMorgan International Research Enhanced Equity ETF (JIRE) stake by 6.6% in Q2 2026, buying an estimated $693K and bringing the position to 139,052 shares worth $11.5M. The position accounts for 1.13% of the portfolio, ranked #19.

Greenwood Capital Associates first reported a position in JIRE in Q4 2024 and has held it in 7 quarters since. 351 funds tracked by Wall St. Rank hold JIRE as of Q2 2026.

  • Greenwood Capital Associates held 139,052 shares of JPMorgan International Research Enhanced Equity ETF worth $11.5M as of Q2 2026.
  • Greenwood Capital Associates bought 8,635 JPMorgan International Research Enhanced Equity ETF shares in Q2 2026, an estimated $693K.
  • JPMorgan International Research Enhanced Equity ETF made up 1.13% of Greenwood Capital Associates's portfolio in Q2 2026, its #19 holding.
  • Greenwood Capital Associates first reported a position in JPMorgan International Research Enhanced Equity ETF in Q4 2024 and has held it in 7 quarters since.
  • 351 funds tracked by Wall St. Rank held JPMorgan International Research Enhanced Equity ETF as of Q2 2026.

Based on Greenwood Capital Associates's 13F filing for Q2 2026, filed 28 Jul 2026.